Cargando…
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis
This study aims at evaluating the combination of the tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL)-receptor 2 (TRAIL-R2)-specific antibody Drozitumab and the Smac mimetic BV6 in preclinical glioblastoma models. To this end, the effect of BV6 and/or Drozitumab on apoptosis induction...
Autores principales: | Cristofanon, S, Abhari, B A, Krueger, M, Tchoghandjian, A, Momma, S, Calaminus, C, Vucic, D, Pichler, B J, Fulda, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650534/ https://www.ncbi.nlm.nih.gov/pubmed/25880091 http://dx.doi.org/10.1038/cddis.2014.592 |
Ejemplares similares
-
Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells
por: Czaplinski, Sebastian, et al.
Publicado: (2015) -
Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells
por: Tchoghandjian, A, et al.
Publicado: (2013) -
Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress
por: Abhari, Behnaz Ahangarian, et al.
Publicado: (2019) -
Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152
por: Tchoghandjian, A, et al.
Publicado: (2016) -
Correction: Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress
por: Abhari, Behnaz Ahangarian, et al.
Publicado: (2020)